Reducing stigma related to HIV among high-risk women who use drugs in Kazakhstan.
Reducing Intersectional and HIV Stigma among High Risk Women who use Drugs in Kazakhstan, Central Asia: A Multilevel Stigma Resistance and Enacted Stigma Reduction Intervention for Women and Providers
This study is looking at how the negative attitudes towards women who use drugs can make it harder for them to get tested and treated for HIV in Kazakhstan, and it aims to create a supportive program that helps both these women and healthcare providers work together to improve access to care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia Univ New York Morningside NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10871873 on NIH RePORTER |
What this research studies
This research aims to address the stigma that high-risk women who use drugs face regarding HIV prevention and care in Kazakhstan. It focuses on understanding how stigma from healthcare providers and society affects these women's access to HIV testing and treatment. The study will develop and evaluate a multi-level intervention designed to reduce both HIV-related stigma and intersectional stigma, thereby improving engagement in HIV care. By involving women and healthcare providers in the intervention design, the research seeks to create a supportive environment that encourages testing and treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are high-risk women in Kazakhstan who use or inject drugs and are affected by HIV stigma.
Not a fit: Patients who do not use drugs or are not at risk for HIV may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve access to HIV prevention and care for high-risk women in Kazakhstan, ultimately reducing new infections and improving health outcomes.
How similar studies have performed: While stigma reduction interventions have been explored in other contexts, this specific approach tailored for high-risk women in Kazakhstan is novel and untested.
Where this research is happening
New York, United States
- Columbia Univ New York Morningside — New York, United States (Active)
Researchers
- Principal investigator: West, Brooke S. — Columbia Univ New York Morningside
- Study coordinator: West, Brooke S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.